[HTML][HTML] Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases
VT Samuel, GI Shulman - Cell metabolism, 2018 - cell.com
NAFLD is closely linked with hepatic insulin resistance. Accumulation of hepatic
diacylglycerol activates PKC-ε, impairing insulin receptor activation and insulin-stimulated …
diacylglycerol activates PKC-ε, impairing insulin receptor activation and insulin-stimulated …
[HTML][HTML] Non-Alcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases
VT Samuel, GI Shulman - Cell metabolism, 2018 - ncbi.nlm.nih.gov
NAFLD is closely linked with hepatic insulin resistance. Accumulation of hepatic
diacylglycerol activates PKC-ε, impairing insulin receptor activation and insulin-stimulated …
diacylglycerol activates PKC-ε, impairing insulin receptor activation and insulin-stimulated …
[引用][C] Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases
VT Samuel, GI Shulman - Cell Metabolism, 2018 - cir.nii.ac.jp
[HTML][HTML] Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases
VT Samuel, GI Shulman - Cell Metabolism, 2018 - Elsevier
NAFLD is closely linked with hepatic insulin resistance. Accumulation of hepatic
diacylglycerol activates PKC-ε, impairing insulin receptor activation and insulin-stimulated …
diacylglycerol activates PKC-ε, impairing insulin receptor activation and insulin-stimulated …
Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases
VT Samuel, GI Shulman - Cell metabolism, 2018 - pubmed.ncbi.nlm.nih.gov
NAFLD is closely linked with hepatic insulin resistance. Accumulation of hepatic
diacylglycerol activates PKC-ε, impairing insulin receptor activation and insulin-stimulated …
diacylglycerol activates PKC-ε, impairing insulin receptor activation and insulin-stimulated …
Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases.
VT Samuel, GI Shulman - Cell Metabolism, 2017 - europepmc.org
NAFLD is closely linked with hepatic insulin resistance. Accumulation of hepatic
diacylglycerol activates PKC-ε, impairing insulin receptor activation and insulin-stimulated …
diacylglycerol activates PKC-ε, impairing insulin receptor activation and insulin-stimulated …